• Explore /
  • Poster
  • / Correlation between immune-related adverse events (irAEs) and efficacy in patients with solid tumors treated with immune-checkpoints inhibitors (ICIs).

Correlation between immune-related adverse events (irAEs) and efficacy in patients with solid tumors treated with immune-checkpoints inhibitors (ICIs).

Abstract Poster

Authors

null

Mariona Riudavets

Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Mariona Riudavets , Andrés Barba , Pablo Maroto , IVANA GABRIELA Sullivan , Georgia Anguera , David Páez , Luis del Carpio , Ana Callejo , Cintia Gonzalez Blanco , Esther Garcia Planellas , Diego Castillo , Carme Facundo , Idoia Genua , Cristina Martin Lorente , Ana Virgili , Ana Sebio , Oscar Gallego , Antonio Lopez-Pousa , Agust Barnadas , Margarita Majem

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research

Sub Track

Immune Checkpoint Inhibitors

Citation

J Clin Oncol 36, 2018 (suppl; abstr 3064)

DOI

10.1200/JCO.2018.36.15_suppl.3064

Abstract #

3064

Poster Bd #

278

Abstract Disclosures

Similar Posters

First Author: Thierry Landre

First Author: Lorenzo Pilla

First Author: Charlee Nardin

First Author: Ranjan Pathak